AU686210B2 - Eosinophil chemotaxis inhibitor - Google Patents

Eosinophil chemotaxis inhibitor Download PDF

Info

Publication number
AU686210B2
AU686210B2 AU72926/94A AU7292694A AU686210B2 AU 686210 B2 AU686210 B2 AU 686210B2 AU 72926/94 A AU72926/94 A AU 72926/94A AU 7292694 A AU7292694 A AU 7292694A AU 686210 B2 AU686210 B2 AU 686210B2
Authority
AU
Australia
Prior art keywords
group
hydrogen atom
atom
alkyl group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU72926/94A
Other languages
English (en)
Other versions
AU7292694A (en
Inventor
Yasuko Ashida
Tatsumi Matsumoto
Akio Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU7292694A publication Critical patent/AU7292694A/en
Application granted granted Critical
Publication of AU686210B2 publication Critical patent/AU686210B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU72926/94A 1993-09-21 1994-09-12 Eosinophil chemotaxis inhibitor Ceased AU686210B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23476493 1993-09-21
JP5-234764 1993-09-21

Publications (2)

Publication Number Publication Date
AU7292694A AU7292694A (en) 1995-04-06
AU686210B2 true AU686210B2 (en) 1998-02-05

Family

ID=16975996

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72926/94A Ceased AU686210B2 (en) 1993-09-21 1994-09-12 Eosinophil chemotaxis inhibitor

Country Status (10)

Country Link
US (2) US5922712A (2)
EP (2) EP0648491A3 (2)
KR (1) KR100280240B1 (2)
CN (1) CN1109885A (2)
AU (1) AU686210B2 (2)
CA (1) CA2132489A1 (2)
FI (1) FI944354A0 (2)
NO (1) NO307547B1 (2)
NZ (1) NZ264479A (2)
TW (1) TW304878B (2)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996008496A1 (en) * 1994-09-16 1996-03-21 Takeda Chemical Industries, Ltd. Triazolopyridazines process and intermediates for their preparation and their use as medicaments
EP0979231B1 (en) 1997-04-25 2004-11-24 Takeda Chemical Industries, Ltd. Condensed pyridazine derivatives, their production and use
CA2319426A1 (en) * 1998-03-04 1999-09-10 Kenichirou Kiyoshima Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases
CA2346659A1 (en) 1998-10-06 2000-04-13 Michiyo Gyoten Condensed pyridazine compounds, their production and use
KR20010087738A (ko) * 1998-10-21 2001-09-21 다케다 야쿠힌 고교 가부시키가이샤 축합 피리다진 유도체, 이의 제조 방법 및 용도
AU7315900A (en) * 1999-09-20 2001-04-24 Takeda Chemical Industries Ltd. Chemokine/cytokine expression inhibitors
AU1054301A (en) * 1999-11-11 2001-06-06 Takeda Chemical Industries Ltd. Nasal drops containing fused pyridazine derivatives
HUE030390T2 (en) 2005-12-21 2017-05-29 Janssen Pharmaceutica Nv Triazolopyridazines as tyrosine kinase modulators

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0185346A2 (de) * 1984-12-21 1986-06-25 Dr. Karl Thomae GmbH Neue Imidazoderivate, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0440119A1 (en) * 1990-01-31 1991-08-07 Takeda Chemical Industries, Ltd. Imidazopyridazine compounds, their production and use
EP0445549A1 (de) * 1990-03-08 1991-09-11 Precitronic Gesellschaft für Feinmechanik und Electronic m.b.H Pyrotechnische Vorrichtung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
PH27291A (en) * 1989-01-31 1993-05-04 Takeda Chemical Industries Ltd Imidazolpyrimidazines their production and use
US5011835A (en) * 1990-02-07 1991-04-30 Merrell Dow Pharmaceuticals Inc. Substituted triazolopyridazines, pharmaceutical compositions and use
ATE117690T1 (de) * 1990-03-01 1995-02-15 Takeda Chemical Industries Ltd Imidazopyridazine, ihre herstellung und verwendung.
FI932687L (fi) * 1990-12-14 1993-06-11 Merrell Dow Pharma Antiallergiska foereningar
TW211013B (2) * 1991-12-27 1993-08-11 Takeda Pharm Industry Co Ltd
LT3200B (en) * 1992-03-18 1995-03-27 Takeda Chemical Industries Ltd Triazolopyridazine methodfor production thereof and use
DE69322673T2 (de) * 1992-03-18 1999-05-06 Takeda Chemical Industries, Ltd., Osaka Imidazopyridazine als Antiasthmatika

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0185346A2 (de) * 1984-12-21 1986-06-25 Dr. Karl Thomae GmbH Neue Imidazoderivate, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0440119A1 (en) * 1990-01-31 1991-08-07 Takeda Chemical Industries, Ltd. Imidazopyridazine compounds, their production and use
EP0445549A1 (de) * 1990-03-08 1991-09-11 Precitronic Gesellschaft für Feinmechanik und Electronic m.b.H Pyrotechnische Vorrichtung

Also Published As

Publication number Publication date
NZ264479A (en) 1999-05-28
EP0648491A2 (en) 1995-04-19
FI944354A0 (fi) 1994-09-20
US5922712A (en) 1999-07-13
KR100280240B1 (ko) 2001-02-01
NO943494L (no) 1995-03-22
US5945419A (en) 1999-08-31
EP0865790A3 (en) 1999-03-10
EP0648491A3 (en) 1995-07-19
NO943494D0 (no) 1994-09-20
AU7292694A (en) 1995-04-06
CA2132489A1 (en) 1995-03-22
CN1109885A (zh) 1995-10-11
TW304878B (2) 1997-05-11
NO307547B1 (no) 2000-04-25
EP0865790A2 (en) 1998-09-23
KR950007851A (ko) 1995-04-15

Similar Documents

Publication Publication Date Title
US5366997A (en) Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
KR20150058154A (ko) 프롤릴 하이드록실라제 억제제 [(4-하이드록시-1-메틸-7-페녹시-아이소퀴놀린-3-카보닐)-아미노]-아세트산의 결정형
AU2014277506A1 (en) Bisulfate of Janus kinase (JAK) inhibitor and preparation method therefor
WO2021060453A1 (ja) 架橋型光学活性２級アミン誘導体
US5547970A (en) Use of leflunomide for inhibiting tumor necrosis factor alpha
RU2034846C1 (ru) СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЙ ГРУППЫ ИМИДАЗО (1,2-b)-ПИРИДАЗИНА ИЛИ ИХ СОЛЕЙ
US5945419A (en) Method for treating allergic rhinitis
CN109928972B (zh) 一种苦参碱衍生物及其在药物中的应用
CN113214275B (zh) 吡喃并咔唑生物碱类衍生物及其治疗神经系统疾病的用途
CA2086164A1 (en) Pyridazine compounds, their production and use
EP0620224B1 (en) Triazolopyridazine derivatives, their production and use
JP2002544258A (ja) イオンチャネル調節剤
CA2492110A1 (en) Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor
JP2002544268A (ja) イオンチャネル調節剤
JPH0640989A (ja) 新規化合物
WO2024235218A1 (zh) Hdac1/2选择性抑制剂及其用途
JP2016520538A (ja) 鉄欠乏症および鉄欠乏性貧血の治療および予防のためのＦｅ（ＩＩＩ）錯体
JP3143697B2 (ja) 好酸球化学遊走抑制剤
CN116768870A (zh) 具有苄氧基芳基醚结构的化合物及其制备方法和用途
JPH0640990A (ja) 新規化合物
JP7835785B2 (ja) シクロヘキセノン化合物の結晶形
CN118812558B (zh) 氧杂黄藤素类化合物及其药物用途
JPH05331063A (ja) エンドセリン受容体拮抗剤
JP3049284B2 (ja) ヒダントイン誘導体並びにそれを有効成分とする糖尿病合併症及び循環器系疾患の予防及び治療剤
WO1984000888A1 (en) Substituted n-benzenesulfonyloxyphthalimides

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired